Moneycontrol
HomeNewsBusinessBusiness activity may not touch pre-COVID-19 levels before March 2021: CARE Ratings Survey
Trending Topics

Business activity may not touch pre-COVID-19 levels before March 2021: CARE Ratings Survey

The smaller businesses have reported more stress than the larger ones in the survey of over 600 companies conducted by CARE Ratings between August 25 and September 13.

September 21, 2020 / 21:48 IST
Story continues below Advertisement

Business activity is unlikely to touch pre-COVID-19 levels before March 2021, and there is a need for the government to step in and give a "push" to the economy as it has not done enough till now, a multi-sector survey conducted by a rating agency has said on Monday.

Story continues below Advertisement

The smaller businesses have reported more stress than the larger ones in the survey of over 600 companies conducted by CARE Ratings between August 25 and September 13.

The economy is set to contract by over 10 percent as per some estimates during 2020-21, which is bound to have an impact on businesses as well.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show